相似文献
1
Editorial: Autoimmune Vasculitis - Advances in Pathogenesis and Therapies.
Front Immunol. 2021 Jun 18;12:720257. doi: 10.3389/fimmu.2021.720257. eCollection 2021.
2
The systemic vasculitides.
Hosp Pract (Off Ed). 1992 Jul 15;27(7):77-81, 85-6, 88. doi: 10.1080/21548331.1992.11705454.
3
[Glomerulonephritis within the scope of primary systemic vasculitis].
Internist (Berl). 1995 Mar;36(3):245-53.
4
[Primary systemic vasculitides. Part III. Pathogenesis and therapy].
Internist (Berl). 1999 Nov;40(11):1194-215. doi: 10.1007/s001080050457.
5
[Eye manifestations in systemic vasculitis].
Ophthalmologe. 1998 Apr;95(4):W266-85. doi: 10.1007/s003470050273.
6
European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL.
Clin Exp Immunol. 1995 Jul;101 Suppl 1(Suppl 1):29-34. doi: 10.1111/j.1365-2249.1995.tb06161.x.
7
Editorial: Autoimmune Blistering Diseases.
Front Immunol. 2020 Jul 22;11:1614. doi: 10.3389/fimmu.2020.01614. eCollection 2020.
8
[Primary systemic vasculitis. II: Disease picture].
Internist (Berl). 1999 Sep;40(9):951-68; quiz 968. doi: 10.1007/s001080050424.
9
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases: Otologic, Sinus, and Airway.
Rheum Dis Clin North Am. 2023 Aug;49(3):633-645. doi: 10.1016/j.rdc.2023.03.012. Epub 2023 Apr 15.
10
[Classification, pathogenesis and therapy of vasculitis].
Vasa Suppl. 1987;20:12-22.
Zotero 插件